Cargando…

Exploration of C-terminal CX3CL1 for reducing age-dependent neurodegeneration

Detalles Bibliográficos
Autores principales:	Hudobenko, Jacob, Gayen, Manoshi, Benoit, Marc R., Singh, Neeraj, Yan, Riqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358647/ https://www.ncbi.nlm.nih.gov/pubmed/37449614 http://dx.doi.org/10.4103/1673-5374.373702

Ejemplares similares

The CX3CL1 intracellular domain exhibits neuroprotection via insulin receptor/insulin-like growth factor receptor signaling
por: Gayen, Manoshi, et al.
Publicado: (2022)

CX3CL1 intracellular domain and adult neurogenesis
por: Benoit, Marc R., et al.
Publicado: (2019)

The intracellular domain of CX3CL1 regulates adult neurogenesis and Alzheimer’s amyloid pathology
por: Fan, Qingyuan, et al.
Publicado: (2019)

Activated CX3CL1/Smad2 Signals Prevent Neuronal Loss and Alzheimer's Tau Pathology-Mediated Cognitive Dysfunction
por: Fan, Qingyuan, et al.
Publicado: (2020)

BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides
por: Zhou, John, et al.
Publicado: (2023)

N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity
por: Kehlen, Astrid, et al.
Publicado: (2017)

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
por: Limatola, Cristina, et al.
Publicado: (2014)

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
por: Pawelec, Paulina, et al.
Publicado: (2020)

Fractalkine/CX3CL1 in Neoplastic Processes
por: Korbecki, Jan, et al.
Publicado: (2020)

Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice
por: Winter, Aimee N., et al.
Publicado: (2020)

CX(3)CR1-CX(3)CL1-dependent cell-to-cell Japanese encephalitis virus transmission by human microglial cells
por: Lannes, Nils, et al.
Publicado: (2019)

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection
por: Chen, Peiqing, et al.
Publicado: (2016)

Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

ERp57 in neurodegeneration and regeneration
por: Bargsted, Leslie, et al.
Publicado: (2016)

Oligomers and Neurodegeneration: New Evidence
por: Forloni, Gianluigi
Publicado: (2023)

Microglia and Aging: The Role of the TREM2–DAP12 and CX3CL1-CX3CR1 Axes
por: Mecca, Carmen, et al.
Publicado: (2018)

Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation
por: Bian, Chao, et al.
Publicado: (2015)

Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease
por: von Vietinghoff, Sibylle, et al.
Publicado: (2021)

Neurodegeneration in branch retinal vein occlusion
por: Alshareef, Rayan A., et al.
Publicado: (2016)

DNA damage and neurodegeneration: the unusual suspect
por: Stein, Daniel, et al.
Publicado: (2017)

Olfactory proteotyping: towards the enlightenment of the neurodegeneration
por: Fernández-Irigoyen, Joaquín, et al.
Publicado: (2019)

CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease
por: Pabon, Mibel M, et al.
Publicado: (2011)

Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats
por: Yang, Jia-Le, et al.
Publicado: (2012)

Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1‐CX3CR1 dependent manner and induce tumour cell apoptosis
por: Miao, Shuo, et al.
Publicado: (2020)

Nature can still be the strongest help against aging and neurodegeneration: the sirtuins way
por: Della-Morte, David, et al.
Publicado: (2022)

CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD
por: Falk, Mads Krüger, et al.
Publicado: (2014)

Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression
por: Zhang, Huili, et al.
Publicado: (2012)

CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
por: Zhuang, Quan, et al.
Publicado: (2017)

CX3CL1–CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis
por: Fernández-Prieto, Marta, et al.
Publicado: (2019)

Neurodegeneration and neuroinflammation: two processes, one target
por: Carriba, Paulina, et al.
Publicado: (2015)

Dendrite pathology and neurodegeneration: focus on mTOR
por: Di Polo, Adriana
Publicado: (2015)

Metabolism, neurodegeneration and epigenetics: emerging role of Sirtuins
por: Silberman, Dafne M.
Publicado: (2018)

Mitochondrial bioenergetics and neurodegeneration: a paso doble
por: Rossi, Alice, et al.
Publicado: (2020)

CD8(+) T cells in neurodegeneration: friend or foe?
por: Hu, Dan, et al.
Publicado: (2022)

Developing drugs targeting CX3CL1 to treat heart diseases via immune/inflammatory mediation: Targeting CX3CL1 to treat heart diseases
por: Zou, Lin, et al.
Publicado: (2023)

Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients
por: Cimato, Thomas R, et al.
Publicado: (2014)

Reduced CX3CL1 Secretion Contributes to the Susceptibility of Oral Leukoplakia-Associated Fibroblasts to Candida albicans
por: Cheng, Ran, et al.
Publicado: (2016)

Diterpenes and the crosstalk with the arachidonic acid pathways, relevance in neurodegeneration
por: Zolezzi, Juan M., et al.
Publicado: (2019)

Neurogenesis versus neurodegeneration: the broken balance in Alzheimer’s disease
por: Polis, Baruh, et al.
Publicado: (2020)

Elucidating the pathological mechanisms of neurodegeneration in the lethal serpinopathy FENIB
por: Miranda, Elena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_871ibqv8gk7it28j1beieicgao